KCNQ4

gene product
DFNA2, Kv7.4
The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The current generated by this channel is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
47 antibodies from 14 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
antibodies-online
13 antibodies
Abnova Corporation
4 antibodies
Atlas Antibodies
1 antibody
Novus Biologicals
7 antibodies
Rockland Immunochemicals, Inc.
1 antibody
Acris Antibodies GmbH
3 antibodies
GeneTex
2 antibodies
Aviva Systems Biology
2 antibodies
LifeSpan BioSciences, Inc.
3 antibodies
Thermo Fisher Scientific Pierce
1 antibody
Everest Biotech
1 antibody
Creative Biomart
5 antibodies
Sigma-Aldrich
3 antibodies
EMD Millipore
1 antibody